NASDAQ · Financial Statements

Cyclacel Pharmaceuticals, Inc. (CYCC) Financial Statements

$6.37 NASDAQ: CYCC Market Cap $10.61M

Cyclacel Pharmaceuticals, Inc. most recently reported annual revenue of $1.0M, net profit of $-3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-23.0M$-28.0M$-25.0M$-12.0M$-8.0M
Net Profit$-19.0M$-21.0M$-23.0M$-11.0M$-3.0M
EPS$-32.10$-28.50$-28.67$-1.36$-6.45
Op Margin——-6060.2%-27916.3%-1128.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$43.0M$28.0M$9.0M$4.0M$8.0M
Total Liabilities$5.0M$8.0M$8.0M$6.0M$1.0M
Cash$37.0M$18.0M$3.0M$3.0M$4.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-21.0M$-16.0M$-8.0M$-5.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$5.0M$0$0$2.0M$0
Net Cash Flow$3.0M$-18.0M$-15.0M$0$0
Free Cash Flow$-19.0M$-21.0M$-16.0M$-8.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.16
EV / EBITDA-4.67
FCF Yield-47.56%
Quick Ratio5.87
Interest Coverage-404111.11
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
CYCC Overview CYCC Dividend Run Stock Screener